Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boostrix booster immunity persistence study in healthcare workers
ACTRN12615001262594Phase 4Completed
- Sponsor
- Kids Research Institute Australia
- Start
- Dec 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of acellular pertussis vaccine in pertussis, diphtheria and Tetanus (2 cohorts), sponsored by Kids Research Institute Australia. Primary endpoints: Pertussis toxin IgG antibody response, Filamentous haemagglutinin IgG antibody response and 1 more. Started Dec 2015; status: completed.
02
Drugs
acellular pertussis vaccine
03
Conditions
pertussisdiphtheriaTetanus
Beyond the preview
Go deeper on ACTRN12615001262594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001262594.